Clinical Trial Update: Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore [NA]

View source ↗

Summary

A completed clinical trial evaluated whether achieving early target trough levels of tacrolimus using CYP3A5-guided dosing provides advantages over standard wei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection
• Kidney Transplantation

Drugs mentioned

• Tacrolimus (Prograf) (tacrolimus)

Snippet

Sponsor: Singapore General Hospital | Conditions: Kidney Transplant Rejection, Kidney Transplant; Complications | NA | Status: COMPLETED